These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

639 related articles for article (PubMed ID: 17825267)

  • 1. AKT1 is associated with schizophrenia across multiple symptom dimensions in the Irish study of high density schizophrenia families.
    Thiselton DL; Vladimirov VI; Kuo PH; McClay J; Wormley B; Fanous A; O'Neill FA; Walsh D; Van den Oord EJ; Kendler KS; Riley BP
    Biol Psychiatry; 2008 Mar; 63(5):449-57. PubMed ID: 17825267
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relationship between a high-risk haplotype in the DTNBP1 (dysbindin) gene and clinical features of schizophrenia.
    Fanous AH; van den Oord EJ; Riley BP; Aggen SH; Neale MC; O'Neill FA; Walsh D; Kendler KS
    Am J Psychiatry; 2005 Oct; 162(10):1824-32. PubMed ID: 16199828
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Further evidence for association of variants in the AKT1 gene with schizophrenia in a sample of European sib-pair families.
    Schwab SG; Hoefgen B; Hanses C; Hassenbach MB; Albus M; Lerer B; Trixler M; Maier W; Wildenauer DB
    Biol Psychiatry; 2005 Sep; 58(6):446-50. PubMed ID: 16026766
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association analysis of AKT1 and schizophrenia in a UK case control sample.
    Norton N; Williams HJ; Dwyer S; Carroll L; Peirce T; Moskvina V; Segurado R; Nikolov I; Williams NM; Ikeda M; Iwata N; Owen MJ; O'Donovan MC
    Schizophr Res; 2007 Jul; 93(1-3):58-65. PubMed ID: 17383860
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetic association of the AKT1 gene with schizophrenia in a British population.
    Mathur A; Law MH; Megson IL; Shaw DJ; Wei J
    Psychiatr Genet; 2010 Jun; 20(3):118-22. PubMed ID: 20421846
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evidence of novel neuronal functions of dysbindin, a susceptibility gene for schizophrenia.
    Numakawa T; Yagasaki Y; Ishimoto T; Okada T; Suzuki T; Iwata N; Ozaki N; Taguchi T; Tatsumi M; Kamijima K; Straub RE; Weinberger DR; Kunugi H; Hashimoto R
    Hum Mol Genet; 2004 Nov; 13(21):2699-708. PubMed ID: 15345706
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of DTNBP1, NRG1, and AKT1 in the genetics of schizophrenia in Finland.
    Turunen JA; Peltonen JO; Pietiläinen OP; Hennah W; Loukola A; Paunio T; Silander K; Ekelund J; Varilo T; Partonen T; Lönnqvist J; Peltonen L
    Schizophr Res; 2007 Mar; 91(1-3):27-36. PubMed ID: 17300918
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MEGF10 association with schizophrenia.
    Chen X; Wang X; Chen Q; Williamson V; van den Oord E; Maher BS; O'Neill FA; Walsh D; Kendler KS
    Biol Psychiatry; 2008 Mar; 63(5):441-8. PubMed ID: 18179784
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Extensive linkage disequilibrium mapping at HTR2A and DRD3 for schizophrenia susceptibility genes in the Galician population.
    Domínguez E; Loza MI; Padín F; Gesteira A; Paz E; Páramo M; Brenlla J; Pumar E; Iglesias F; Cibeira A; Castro M; Caruncho H; Carracedo A; Costas J
    Schizophr Res; 2007 Feb; 90(1-3):123-9. PubMed ID: 17125970
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biological validation of increased schizophrenia risk with NRG1, ERBB4, and AKT1 epistasis via functional neuroimaging in healthy controls.
    Nicodemus KK; Law AJ; Radulescu E; Luna A; Kolachana B; Vakkalanka R; Rujescu D; Giegling I; Straub RE; McGee K; Gold B; Dean M; Muglia P; Callicott JH; Tan HY; Weinberger DR
    Arch Gen Psychiatry; 2010 Oct; 67(10):991-1001. PubMed ID: 20921115
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of AKT1 gene variants and protein expression in both schizophrenia and bipolar disorder.
    Karege F; Perroud N; Schürhoff F; Méary A; Marillier G; Burkhardt S; Ballmann E; Fernandez R; Jamain S; Leboyer M; La Harpe R; Malafosse A
    Genes Brain Behav; 2010 Jul; 9(5):503-11. PubMed ID: 20214684
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of AKT1 haplotype with the risk of schizophrenia in Iranian population.
    Bajestan SN; Sabouri AH; Nakamura M; Takashima H; Keikhaee MR; Behdani F; Fayyazi MR; Sargolzaee MR; Bajestan MN; Sabouri Z; Khayami E; Haghighi S; Hashemi SB; Eiraku N; Tufani H; Najmabadi H; Arimura K; Sano A; Osame M
    Am J Med Genet B Neuropsychiatr Genet; 2006 Jun; 141B(4):383-6. PubMed ID: 16583435
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The trace amine associated receptor (TAAR6) gene is not associated with schizophrenia in the Irish Case-Control Study of Schizophrenia (ICCSS) sample.
    Vladimirov VI; Maher BS; Wormley B; O'Neill FA; Walsh D; Kendler KS; Riley BP
    Schizophr Res; 2009 Feb; 107(2-3):249-54. PubMed ID: 18973992
    [TBL] [Abstract][Full Text] [Related]  

  • 14. DTNBP1 haplotype influences baseline assessment scores of schizophrenic in-patients.
    Pae CU; Drago A; Kim JJ; Patkar AA; Jun TY; Lee C; Mandelli L; De Ronchi D; Paik IH; Serretti A
    Neurosci Lett; 2008 Aug; 440(2):150-4. PubMed ID: 18562100
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of a high-risk haplotype for the dystrobrevin binding protein 1 (DTNBP1) gene in the Irish study of high-density schizophrenia families.
    van den Oord EJ; Sullivan PF; Jiang Y; Walsh D; O'Neill FA; Kendler KS; Riley BP
    Mol Psychiatry; 2003 May; 8(5):499-510. PubMed ID: 12808430
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association between AKT1 but not AKTIP genetic variants and increased risk for suicidal behavior in bipolar patients.
    Magno LA; Miranda DM; Neves FS; Pimenta GJ; Mello MP; De Marco LA; Correa H; Romano-Silva MA
    Genes Brain Behav; 2010 Jun; 9(4):411-8. PubMed ID: 20132317
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The dystrobrevin binding protein 1 (DTNBP1) gene is associated with schizophrenia in the Irish Case Control Study of Schizophrenia (ICCSS) sample.
    Riley B; Kuo PH; Maher BS; Fanous AH; Sun J; Wormley B; O'Neill FA; Walsh D; Zhao Z; Kendler KS
    Schizophr Res; 2009 Dec; 115(2-3):245-53. PubMed ID: 19800201
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bipolar disorder and polymorphisms in the dysbindin gene (DTNBP1).
    Raybould R; Green EK; MacGregor S; Gordon-Smith K; Heron J; Hyde S; Caesar S; Nikolov I; Williams N; Jones L; O'Donovan MC; Owen MJ; Jones I; Kirov G; Craddock N
    Biol Psychiatry; 2005 Apr; 57(7):696-701. PubMed ID: 15820225
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Variation at the DAOA/G30 locus influences susceptibility to major mood episodes but not psychosis in schizophrenia and bipolar disorder.
    Williams NM; Green EK; Macgregor S; Dwyer S; Norton N; Williams H; Raybould R; Grozeva D; Hamshere M; Zammit S; Jones L; Cardno A; Kirov G; Jones I; O'Donovan MC; Owen MJ; Craddock N
    Arch Gen Psychiatry; 2006 Apr; 63(4):366-73. PubMed ID: 16585465
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Failure to support a genetic contribution of AKT1 polymorphisms and altered AKT signaling in schizophrenia.
    Ide M; Ohnishi T; Murayama M; Matsumoto I; Yamada K; Iwayama Y; Dedova I; Toyota T; Asada T; Takashima A; Yoshikawa T
    J Neurochem; 2006 Oct; 99(1):277-87. PubMed ID: 16987250
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 32.